CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-15 | Labrucherie Gil M SVP, COO & CFO | Grant or award | +40,150 | 280,831 | ||
| 2021-11-11 | Brainard Diana Director | Grant or award | +18,360 | 18,360 | ||
| 2021-11-11 | Brainard Diana Director | Grant or award · Stock Option | +36,720 | 36,720 | ||
| 2021-11-09 | GREER R SCOTT Director | Option exercise | +12,500 | $12.80 | $160K | 293,374 |
| 2021-11-09 | GREER R SCOTT Director | Option exercise · Stock Option | −12,500 | 0 | ||
| 2021-10-12 | Zalevsky Jonathan Chief R&D Officer | Grant or award · Stock Option | +71,550 | 71,550 | ||
| 2021-10-12 | Wilson Mark Andrew SVP & General Counsel | Grant or award · Stock Option | +35,800 | 35,800 | ||
| 2021-10-12 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +26,600 | 26,600 | ||
| 2021-10-12 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +167,650 | 167,650 | ||
| 2021-10-12 | Labrucherie Gil M SVP, COO & CFO | Grant or award · Stock Option | +71,550 | 71,550 | ||
| 2021-09-22 | WHITFIELD ROY A Director | Grant or award | +10,200 | 236,050 | ||
| 2021-09-22 | WHITFIELD ROY A Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2021-09-22 | GREER R SCOTT Director | Grant or award | +10,200 | 280,874 | ||
| 2021-09-22 | GREER R SCOTT Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2021-09-22 | EASTHAM KARIN Director | Grant or award | +10,200 | 34,300 | ||
| 2021-09-22 | EASTHAM KARIN Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2021-09-22 | Curet Myriam Director | Grant or award | +10,200 | 29,440 | ||
| 2021-09-22 | Curet Myriam Director | Sale | −3,665 | $17.78 | $65K | 25,775 |
| 2021-09-22 | Curet Myriam Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2021-09-22 | CHESS ROBERT Director | Grant or award | +10,200 | 284,473 |
Page 11 of 18 · 355 trades